Close
Nordic 9Nordic 9

Swanbridge Capital (investor - Venture Capital)

Netherlands swanbridgecapital.nl
See something wrong or missing? Let us know
Offices:Rotterdam

Swanbridge Capital is a Dutch, Rotterdam-based venture capital fund actively investing in young, high potential companies active in the field of therapeutics

Average round investment:9.83M USD
Average number per year:2.0
Distribution: 2024 (3)2023 (1)
Portfolio companies: Netherlands Spatium MedicalNetherlands Pan CancerNetherlands Flindr Therapeutics
Mostly invests in: Netherlands Netherlands (4) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Swanbridge Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Swanbridge Capital

Name Criteria
Switzerland SAGANA
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Netherlands Delft Enterprises
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Luxembourg i&i Biotech Fund
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Goodface Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Netherlands Van Herk Ventures
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Paul Forster
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 5.1
  • Active last 12 months: Yes
United States Adjacent
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Climate Capital
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Netherlands Horticoop
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Erasmus MC
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top